Compare Paninvest Tbk. (PNIN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paninvest Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Paninvest Tbk. trades at Rp725 (market cap 2.93T, 435.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Paninvest Tbk. is far larger — about 28.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PNIN | SCPI | |
|---|---|---|
Market Cap | 2.93T | 104.4B |
Volume | 435.7K | — |
Lot | 4.36K | — |
Turnover | 315.34M | — |
Average Price | 723.75 | — |
Value | 315.34M | — |
Indicative Equilibrium Price | 725 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paninvest Tbk.
PT Paninvest Tbk formerly PT Panin Insurance Tbk (the Company) was established in Jakarta under the name PT Pan-Union Insurance Ltd., based on Notarial Deed No. 84 dated October 24, 1973 of Notary Juliaan Nimrod Siregar Gelar Mangaradja Namora, S.H. The Company is one of the companies under Pan Indonesia (Panin) Group. Based on the Minutes of General Shareholders's Meeting held on June 28, 2013 which was notarized in Notarial Deed of Kumala Tjahjani Widodo, S.H., M.H.,Mkn., No.78, dated June 28, 2013, the shareholders agree the plan to change the Company's main business activity from general insurance company to tourism and transferred its general insurance portfolio along with portion of its assets and liabilities related to general insurance business to PT Asuransi Umum Panin, subsidiary.
Read more on PNIN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
